EBS - Emergent BioSolutions secures $17M contract modification for oral suspension TEMBEXA
2025-09-15 08:54:29 ET
More on Emergent Biosolutions
- Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally
- Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful
- Mpox in Africa is no longer a global health emergency, WHO chief says
- Emergent Biosolutions awarded $30 million contract modification for CYFENDUS